Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Dana Varon, ARNP

University of Washington

Disclosure(s): No financial relationships to disclose

Poster(s):

101 - Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA): A Randomized, Placebo-Controlled Trial
Thursday, October 20, 2022
12:15 PM – 1:30 PM US ET
1948 - Evaluation of a heterologous booster vaccine regimen: Pfizer-BioNTech BNT162b2 mRNA booster vaccine following priming with Novavax NVX-CoV2373
Saturday, October 22, 2022
12:15 PM – 1:30 PM US ET